A $10 Billion Biotech Sets Four-Year Target for Creating a Rhino

A $10 Billion Biotech Sets Four-Year Target for Creating a Rhino

A biotech valued at $10 billion and scientists from around the world aim to apply gene editing and use a surrogate mother to begin bringing back the northern white rhino from the brink of extinction within four years.